Guidelines for the genetic diagnosis of hereditary recurrent fevers

Yael Shinar(Inserm), Laura Obici(Istituti di Ricovero e Cura a Carattere Scientifico), Ivona Aksentijevich(National Human Genome Research Institute), Bruce Bennetts(Children's Hospital at Westmead), F Austrup(Prosper Hospital), Isabella Ceccherini(Istituto Giannina Gaslini), Juliana M Costa, Anne De Leener(Erasmus Hospital), Marco Gattorno(Istituto Giannina Gaslini), U Kania(Jagiellonian University), Isabelle Kone‐Paut(Centre de Référence des Maladies Autoinflammatoires et des Amyloses), S Lezer(Pronto Diagnostics (Israel)), Avi Livneh(Sheba Medical Center), Isabelle Moix(Geneva College), Ryuta Nishikomori(Kyoto University), Seza Özen(Hacettepe University), Leonidas A. Phylactou(Cyprus Institute of Neurology and Genetics), Lotte Risom(Copenhagen University Hospital), DM Rowczenio(University College London), Tamara Sarkisian(Center of Medical Genetics and Primary Health Care), Mariëlle van Gijn(University Medical Center Utrecht), Martina Witsch‐Baumgartner(Innsbruck Medical University), Michael A. Morris, H. Hoffman(University of California, San Diego), Isabelle Touitou(Université de Montpellier)
Annals of the Rheumatic Diseases
June 2, 2012
Cited by 197Open Access
Full Text

Abstract

Hereditary recurrent fevers (HRFs) are a group of monogenic autoinflammatory diseases characterised by recurrent bouts of fever and serosal inflammation that are caused by pathogenic variants in genes important for the regulation of innate immunity. Discovery of the molecular defects responsible for these diseases has initiated genetic diagnostics in many countries around the world, including the Middle East, Europe, USA, Japan and Australia. However, diverse testing methods and reporting practices are employed and there is a clear need for consensus guidelines for HRF genetic testing. Draft guidelines were prepared based on current practice deduced from previous HRF external quality assurance schemes and data from the literature. The draft document was disseminated through the European Molecular Genetics Quality Network for broader consultation and amendment. A workshop was held in Bruges (Belgium) on 18 and 19 September 2011 to ratify the draft and obtain a final consensus document. An agreed set of best practice guidelines was proposed for genetic diagnostic testing of HRFs, for reporting the genetic results and for defining their clinical significance.


Related Papers

No related papers found

Powered by citation graph analysis